CTOs on the Move


 
Founded in 2016, Huupe is the first-ever smart basketball hoop. It brings competition and training to basketball enthusiasts and players, including NBA athletes as well as stars from the league who have invested in the company. Huupe`s groundbreaking innovation enables ages eight and up to compete on the court or virtually, learn and improve their skills, track their progress, and more. The appointment of Paul as CTO follows the company`s 400% growth month over month in the past six months this year, with 50% growth in October 2022 alone, and viral popularity on social media.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

V Shred

The Vinsanity Shred is a brand with many different products and online personal training and meal plans that are guaranteed to get you your dream body.

MegaFood

Multivitamins and supplements made with whole food and added nutrients. Non-GMO, organic, vegetarian and certified glyphosate residue free supplements for men, women and kids.

Gracepoint

Since 1949, Gracepoint has cared for people like Rachel who needed a combination of intense therapies combined into her school day to thrive, graduate and find a job she loves. At Gracepoint, adults and children and their families have access to 26 board-certified psychiatrists, therapeutic specialists and 26 locations throughout Tampa Bay. Gracepoint`s mission is educating, advocating and giving hope to people touched by behavioral health and developmental challenges.

HemiData

HemiData is a Rochester, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroPace

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world`s first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company`s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.